Posted by AGORACOM-JC
at 7:35 AM on Tuesday, August 13th, 2019
Spyder to open 5 hemp boutique locations at Tanger Outlet centers throughout the United States
Agreement will expand Spyder’s physical footprint to a projected 11 total locations by the end of this year
Potential for additional locations in the future
Vaughan, ON, August 13, 2019, Spyder Cannabis Inc. (“Spyder“), an established Canadian cannabis and vape retail operator, announced today an arrangement through which Spyder will open 5 hemp boutique locations with potential for more at Tanger Outlet centers throughout the United States.
This agreement will expand
Spyder’s physical footprint to a projected 11 total locations by the end of
this year, with the potential for additional locations in the future. “Tanger Outlet operates 39 upscale outlet
shopping centers located in 20 states coast to coast and will allow us access
to millions of consumers,†stated Daniel Pelchovitz, CEO and President of Spyder. “They offer a superior outlet experience and deep tenant
relationships, and we are excited to introduce our hemp retail to their
centers.â€
These boutiques will stock Spyder’s SPDR (R)
branded hemp derived, and
infused products developed for an aging, health and wellness
demographic. Spyder will offer a wide array of hemp product
offerings including; hemp -infused muscle balm, face oil, body lotion and bath
salts, as well as hemp tinctures,
capsules and sprays.
The hemp industry is booming
and has the potential to become a $22 billion business by 2022, according to
cannabis-focused research firm Brightfield Group. Spyder plans on executing an
aggressive expansion plan to create a significant retail brand in the U.S. hemp
market and is committed to developing and acquiring prime North American retail
locations and continuing to build its fast growing brand.
About Spyder Cannabis
Founded
in 2014 Spyder is an established chain of three high-end vape stores, and
two cannabis accessory stores, in Ontario, with locations
in Woodbridge, Scarborough, Burlington, Pickering and Niagara
Falls. The Spyder brand is defined by its high-quality proprietary line of
e-juice, liquids and exclusive retail deals, dispensed in uniquely designed
stores creating the optimal customer experience. Spyder is building off
this leading retail, distribution and branding eCig and vapes company and is pursuing
expansion into the legal cannabis and hemp derived market. Spyder has
developed a scalable retail model with plans to create a significant footprint
with targeted and disciplined retail distribution strategy focusing on Canadian
retail and U.S. boutique retail and kiosks in high traffic peripheral areas
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, otc, stocks, tsx, tsx-v, weed Posted in Featured, Spyder Cannabis Inc. | Comments Off on BREAKING: Spyder Cannabis $SPDR.ca Signs Retail Agreement with Tanger Outlet $SKT Gaining Access to Millions of Consumers Coast-to-Coast in the U.S. $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 10:54 AM on Monday, August 12th, 2019
SPONSOR: Bougainville
Ventures Inc (CSE: BOG) provides strategic capital to the thriving
cannabis cultivation sector through ownership and development of
commercial real estate properties. The company also offers fully built
out turnkey facilities equipped with state-of-the-art growing
infrastructure to cannabis growers and processors. Click here for more info.
—————–
Using CBD Has Never Been More Popular For Americans
Reasons why Americans are turning to CBD vary across the board, but pain relief ranks highest at 40%.
Whatever notions that CBD was just another wellness fad are officially dead. Need proof? Look no further than a Gallup poll released earlier this week.
While federal regulations around CBD remain unsettled for now, the legalization of hemp in 2018
allowed access to CBD to explode throughout the country. The poll found
that younger Americans and those living Western states are more likely
to admit using CBD. However, it’s worth noting 50% of Americans still
don’t consume CBD, with another 35% confessing they have no familiarity
with CBD products at all.
Amongst those aged 30 or younger, CBD usage jumps to 20% and lack of
knowledge around CBD products drops to 26%. Those numbers reverse for
older demographics. Both these trends mirror what previous Gallup polls
found in marijuana usage, as younger people reporting more consumption
while older folks less.
The reasons why Americans are turning to CBD vary across the board,
with pain relief ranking highest at 40%. Other major reasons for
American CBD usage include anxiety (20%), insomnia (11%), and arthritis
(8%). That said, women were more likely than men to use CBD to relieve
anxiety symptoms (25% vs. 14%), while men turned to CBD as a sleep aid
more than women (15% vs. 8%).
And though the majority of Americans report using CBD for medical and
therapeutic relief, 5% of respondents admit to recreational usage of
CBD.
Though CBD proliferating through the United States
might give cannabis enthusiasts cheer, it’s equally important for
consumers to recognize whether they’re purchasing the real deal or
expensive snake oil. Remember, misinformation around CBD can be
life-threatening, especially when using for medicinal purposes. It’s
important to buy high-quality CBD
products and be able to spot fake CBD in the wild. While CBD oil might
be the most popular delivery vehicle, be sure to check out other forms
if curious.
Posted by AGORACOM-JC
at 8:18 AM on Monday, August 12th, 2019
Announced it has received approval from SQUARE, Inc. to accept card payments
Patients and customers can now purchase hemp-derived CBD products and diverse wellness products from Empower Clinics & Sun Valley Health online and in-store using the SQUARE payment processing system
VANCOUVER, Aug. 12, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (OTC: EPWCF) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., is pleased to announce it has received approval from SQUARE, Inc. to accept card payments from customers that want to purchase CBD products and other wellness products from the Company in clinics, stores and online.
Patients and customers can now purchase hemp-derived CBD products and
diverse wellness products from Empower Clinics & Sun Valley Health
online and in-store using the SQUARE payment processing system, ensuring
ease-of-use and a positive checkout experience.
“Providing our patients and customers with card payment options for
CBD product purchases is imperative and the fact that SQUARE has
approved us, affirms our professionalism and operating standards.” said Steven McAuley,
Empowers Chairman & CEO. “The addition of SQUARE merchant services
provides our customers the ability to purchase products in a simple and
user-friendly manner, something that we all take for granted each day.”
Square tells its users online that, “We believe everyone should be
able to participate and thrive in the economy.” They also say “That no
one should be left out of the economy because the cost is too great, or
the technology too complex.”
Merchant services enable businesses to accept credit and debit card
payments from customers. Empower Clinics and its subsidiaries, have
stable and strong partnerships with commercial banking providers in the
Pacific Northwest and in Arizona.
About SQUARE
Square, Inc. is a financial services and merchant services aggregator, and mobile payment company based in San Francisco, California. The company markets several software and hardware payments products and has expanded into small business services.
ABOUT EMPOWER
Empower is a vertically integrated and growth-oriented CBD life
sciences company, and a multi-state operator of medical health &
wellness clinics, operating the Sun Valley Health clinic brand www.sunvalleyhealth.com, for its nine corporate locations and for franchises in the United States.
As a CBD product manufacturer under the Sollievo brand, the company
distributes its lines through clinics, online and through retail
partners. Extraction operations are currently being developed in the
Company’s new extraction facility in Oregon.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley Chief Executive Officer
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws. All
statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release. Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding; the Company’s intention to open a hemp-based CBD
extraction facility, the expected benefits to the Company and its
shareholders as a result of the proposed acquisitions and partnerships;
the terms of the proposed acquisitions and partnerships; the
effectiveness of the extraction technology; the expected benefits for
Empower’s patient base and customers; the benefits of CBD based
products; the effect of the approval of the Farm Bill; the growth of the
Company’s patient list and that the Company will be positioned to be a
market-leading service provider for complex patient requirements in 2019
and beyond. Such statements are only projections, are based on
assumptions known to management at this time, and are subject to risks
and uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
forward-looking statements, including; that the Company may not open a
hemp-based CBD extraction facility; that the hemp-based CBD extraction
facility may not be fully operation by Q2 2019 if at all; that
legislative changes may have an adverse effect on the Company’s business
and product development; that the Company may not be able to obtain
adequate financing to pursue its business plan; general business,
economic, competitive, political and social uncertainties; failure to
obtain any necessary approvals in connection with the proposed
acquisitions and partnerships; and other factors beyond the Company’s
control. No assurance can be given that any of the events anticipated by
the forward-looking statements will occur or, if they do occur, what
benefits the Company will obtain from them. Readers are cautioned not to
place undue reliance on the forward-looking statements in this release,
which are qualified in their entirety by these cautionary statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements in this release, whether as a result of new information,
future events or otherwise, except as expressly required by applicable
laws.
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, otc, stocks, tsx, tsx-v, weed Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Receives Approval from #SQUARE to Process #CBD Product Sales in Clinics, Stores, Online, and throughout the Company Network Nationwide in the U.S. $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 2:30 PM on Friday, August 9th, 2019
(CSE: CBDT) (Frankfurt 8EC) (OTC: EPWCF)
Why Empower Clinics
A leading owner/operator of physician staffed health and pain management clinics.
Patient database of over 165,000 patientsÂ
Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
Launching CBD extraction facility
First extraction system capacity = 6,000 Kg per year.
CBD based products are poised to be a $20B global industry by 2022
Medical cannabis is poised to be a $100B global industry by 2025
Recent Acquisition of Sun Valley Certification Clinics Holdings LLC
Created one of the largest clinic groups in the medical cannabis sector in the United States
Twelve (combined) clinic locations
Combined patient count of 165,000 patients
Platform generating $5MM USD in revenue annually (2020)
Operating in Washington, Oregon, Arizona, Nevada and California
According to the Brightï¬eld Group report the CBD market in the U.S. has grown over 700% in 2019
The CBD industry is becoming much more
saturated than it was before the passing of the U.S. Farm Bill late last
year, with new products entering the market, threatening to take a
slice of the CBD pie that the early producers of CBD have enjoyed until
this time.
Nevertheless, the top 20 CBD companies still hold a majority of the even bigger pie that is CBD in the cannabis industry.
Technology
Developed proprietary software to manage patients through the medical cannabis process
A HIPAA compliant Electronic Health Record (EHR) system and patient management portal.
Tele-medicine platform to serve and treat patients remotely.
Launching an e-Commerce platform for it’s Sollievo and Sun Valley CBD product lines.
Products
Commenced selling its proprietary line of CBD-based products called SOLLIEVO
Empower’s patient base and customers are
expected to benefit from access to high margin derivative products,
including CBD lotion, tinctures, spectrum oils, capsules, lozenges,
patches, e-drinks, topical lotions, gel caps, hemp extract drops and pet
elixir hemp extract drops.
Patients and customers will be able to access Empower’s home delivery and e-commerce platform.
CBD Extraction
Opening first CBD Extraction facility in Portland, OR.
5,000 sq. ft. leased building with first extraction system capable
of producing 20kg per day of 99% spectrum oil, isolate or distillate
Current wholesale pricing is $6,500 USD per kg with annual capacity of 6,000kg an estimated $39MM USD revenue.
Facility can scale to four extraction systems for up to 24,000kg of product and over $150MM USD revenue
Franchising
Completed it’s 2019 Franchise Disclosure Document (FDD) and has commenced selling Sun Valley Health franchises in the United States.
Company is now selling Sun Valley Health franchises and is accepting franchise applications effectively immediately.
Invested in the development of a new
franchise trade show booth that showcases the Sun Valley Health
opportunity to perspective franchisees using dynamic, content rich
displays and four large format television monitors to present features
and benefits.
Posted by AGORACOM-JC
at 2:56 PM on Thursday, August 8th, 2019
SPONSOR: Spyder Cannabis Inc.
(TSX-V: SPDR) An established chain of high-end vape stores in Ontario,
Canada. The company has an aggressive expansion plan already in place
that will focus on Canadian retail and US Hemp-Derived kiosks in high
traffic areas. Click here for more info.
(TSX-V: SPDR)
A new report projects nearly $24 billion in U.S. cannabidiol sales by 2023.
By: Sean Williams
It’s no secret by now that the marijuana industry is a big-money business.
Having grown from $3.4 billion in legal global sales in 2014 to hit nearly $11 billion worldwide in 2018, it demonstrates just how quickly “going green” is catching on with consumers and investors.
However, there’s a potentially larger growth trend contained within the cannabis movement that investors simply have to know about: Cannabidiol (CBD).
Image source: Getty Images.
CBD growth could be off the charts
Cannabidiol is the nonpsychoactive cannabinoid that’s best known for
its perceived medical benefits. Since products infused with CBD don’t
get the user high, it has substantially broader appeal than products
containing tetrahydrocannabinol (THC), the cannabinoid that gives
consumers a buzz.
Further, CBD can be extracted from both the cannabis and hemp plant,
whereas THC derives almost entirely from the cannabis plant, since hemp
often contains very low levels of THC. Hemp plants are considerably
cheaper to grow than cannabis, making hemp the preferred crop choice for CBD extraction.
The big question is: Just how big could the CBD market be?
In a newly released report from Brightfield, the company is calling
for year-over-year CBD product sales growth in the United States of 706%
in 2019 to around $5 billion — not a typo – and sales of $23.7 billion
by 2023. Comparatively, about $620 million worth of CBD products were
sold last year in the United States (based on 706% growth to $5
billion). Growing CBD revenue from about $620 million in 2018 to $23.7
billion by 2023 works out to (drum roll) a compound annual growth rate
(CAGR) of a whopping 107%! Compare that to some of the most robust
broad-based growth estimates for cannabis, which call for a CAGR of
around 25%, and you can see why CBD is all the buzz (without creating an
actual buzz) on Wall Street.
Probably the next question on your mind is: How is such phenomenal growth possible?
According to the Brightfield Group, there are a number of catalysts fueling CBD’s rise.
Image source: Getty Images.
General retailers are stepping up
First, it sees significant sales growth from the entrance of major pharmacy chains into the CBD space. As you may be aware, CVS Health (NYSE:CVS) kicked things off in March by announcing plans to carry CBD topicals in approximately 800 stores across eight states. Walgreens Boots Alliance (NASDAQ:WBA) followed suit just days later by announcing its intention to carry CBD topicals in 1,500 stores in a handful of states. Rite Aid (NYSE:RAD) was last to join the party, with the company carrying CBD topicals in Washington and Oregon.
Traditionally, pharmacy chains are a low-margin business. Though the
bulk of profits are derived from the pharmacy side of the equation,
front-end store products are what can drive consumer loyalty and foot
traffic. By adding CBD products to their stores, CVS Health, Walgreens
Boots Alliance, and Rite Aid, are likely hoping that it brings in repeat
business and new consumers.
Don’t overlook the role CVS Health, Walgreens, and Rite Aid have
played in paving the way for other general retailers to carry CBD
products. National grocery chain Kroger (NYSE:KR) recently announced plans to carry CBD items in 17 states, with Harvest Health & Recreation landing a game-changing partnership to supply CBD products to at least 10,000 gas-station convenience stores.
Image source: Getty Images.
Canadian licensed producers will soon make their mark
Secondly, Brightfield Group notes that Canadian marijuana producers entering the U.S. hemp market are bound to make a splash.
To date, nearly half of Canada’s major growers
(i.e., those capable of at least 100,000 kilos of cannabis output per
year) have announced their intention to enter the U.S. hemp market. This
has been made possible as a result of President Trump signing the farm
bill into law in December. This law legalizes the industrial production
of hemp and hemp-derived CBD.
Posted by AGORACOM-JC
at 8:25 AM on Thursday, August 8th, 2019
Announced it’s Oregon State subsidiary, Empower Healthcare Corp. has been awarded it’s Hemp-Handlers License from the Oregon Department of Agriculture (ODA)
Under license number AG-R1062748IHH, allowing the Company to commence build-out and operate the new 5,000 sq. ft. extraction facility in Sandy, OR.
VANCOUVER, Aug. 8, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (OTC: EPWCF) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., is pleased to announce it’s Oregon State subsidiary, Empower Healthcare Corp. has been awarded it’s Hemp-Handlers License from the Oregon Department of Agriculture (ODA) under license number AG-R1062748IHH, allowing the Company to commence build-out and operate the new 5,000 sq. ft. extraction facility in Sandy, OR.
The Company has also commenced the application process with the
Oregon Department of Agriculture for the Food Establishment Plan permit
that will allow the Company to manufacturer and produce a wide array of
edible products in the new facility or in an adjacent location. Popular
edible CBD products can include gummies, drinks & beverages,
chocolate, pantry items such as peanut butter and honey and baked goods.
“The ODA has strict requirements regarding the award of a
hemp-handlers license and/or a Food Establishment permit, to ensure that
extraction operators and CBD product producers operate to the highest
of standards.” said Steven McAuley, Empowers Chairman &
CEO. “The award of the hemp-handlers license is a significant milestone
for our company as we continue on our path of growth and vertical
integration.”
The Company, with the support of the team at Pathangay Architects www.pathangayarchitects.com
is now able to move into the next phase of facility design and building
permit applications based on the ODA license approval. Preliminary
security systems and IT networks have been installed and the Company
anticipates draft architectural drawings to be completed in Q3 2019 and
initial extraction equipment orders to be placed.
ABOUT EMPOWER
Empower is a vertically integrated and growth-oriented CBD life
sciences company, and a multi-state operator of medical health &
wellness clinics, operating the Sun Valley Health clinic brand www.sunvalleyhealth.com, for its nine corporate locations and for franchises in the United States.
As a CBD product manufacturer under the Solievo brand, the company
distributes its lines through clinics, online and through retail
partners. Extraction operations are currently being developed in the
Company’s new extraction facility in Oregon.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley Chief Executive Officer
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws. All
statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release. Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding; the Company’s intention to open a hemp-based CBD
extraction facility; the effectiveness of the extraction technology; the
expected benefits for Empower’s patient base and customers; the
benefits of CBD based products; the effect of the approval of the Farm
Bill; the growth of the Company’s patient list and that the Company will
be positioned to be a market-leading service provider for complex
patient requirements in 2019 and beyond. Such statements are only
projections, are based on assumptions known to management at this time,
and are subject to risks and uncertainties that may cause actual
results, performance or developments to differ materially from those
contained in the forward-looking statements, including; that the Company
may not open a hemp-based CBD extraction facility; that the hemp-based
CBD extraction facility may not be fully operation by Q3 2019 if at all;
that legislative changes may have an adverse effect on the Company’s
business and product development; that the Company may not be able to
obtain adequate financing to pursue its business plan; general business,
economic, competitive, political and social uncertainties; failure to
obtain any necessary approvals in connection with the proposed
acquisitions and partnerships; and other factors beyond the Company’s
control. No assurance can be given that any of the events anticipated by
the forward-looking statements will occur or, if they do occur, what
benefits the Company will obtain from them. Readers are cautioned not to
place undue reliance on the forward-looking statements in this release,
which are qualified in their entirety by these cautionary statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements in this release, whether as a result of new information,
future events or otherwise, except as expressly required by applicable
laws.
Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019
Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in All Recent Posts, Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Receives its #Hemp-Handlers Licence from Oregon Department of Agriculture and Commences Food Establishment Application to Produce Edibles $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 11:09 AM on Wednesday, August 7th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.
NBUD: CSE
Drink Makers Seek to Include CBD and Cannabis Beverage Alternatives
According to data compiled by Fior Markets, the global cannabis beverages market is expected to reach USD 4.56 Billion by 2025 while exhibiting a CAGR of 16.8% during the forecast period from 2018 to 2025.
In particular, edibles are more abundant in regions where recreational cannabis is legal. On the other hand, the cannabis-infused beverage industry is experiencing significant strength because of large beverage corporations entering into the marketspace.
NEW YORK, Aug. 7, 2019 — As the cannabis industry continues to develop, savvy consumers and businesses are creating innovative new ways to ingest cannabis. Due to widespread stereotypes, many imagine cannabis users relying on hastily rolled joints. However, as the legal industry continues to accelerate, new products are constantly emerging. For instance, in legal markets such as Colorado or California, extracts and concentrates have become increasingly popular because of their potency and immediate effects. Specifically, Colorado has witnessed its extract and concentrate sales eclipse its flower sales in recent years. And while extracts and concentrates are widely popular, other vendors have incorporated cannabis into edibles and beverages.
In particular, edibles are more abundant in regions where
recreational cannabis is legal. On the other hand, the cannabis-infused
beverage industry is experiencing significant strength because of large
beverage corporations entering into the marketspace. Notably, big
alcohol has set its sights on the cannabis market because of its
declining primary revenue drivers. As a result, many companies are
adding cannabis-infused beverages to their product lines in order to
combat lower sales numbers that are a result of the declining alcohol
consumption levels. However, to note, most companies are predominantly
only adding CBD, or cannabidiol, to their beverages because of
regulatory restrictions on THC.
Moreover, companies are marketing CBD-infused beverages as health and
wellness products rather than recreational or relaxation products. And
while the infused beverage market is already experiencing a surge in
momentum in legal regions, it’s expansion into new territories is
expected to spur its growth. According to data compiled by Fior Markets,
the global cannabis beverages market is expected to reach USD 4.56 Billion by 2025 while exhibiting a CAGR of 16.8% during the forecast period from 2018 to 2025.
Tags: Cannabis, CBD, CSE, Hemp, Marijuana, otc, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Drink Makers Seek to Include #CBD and #Cannabis Beverage Alternatives $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 8:35 AM on Wednesday, August 7th, 2019
Entered into a strategic partnership with Endocanna Health Inc. a research and development biotechnology company specializing in endocannabinioid DNA testing, and a partly owned subsidiary of Heritage Cannabis (CSE: CANN)
Endocanna will manufacture its patent-pending Endocannabinoid DNA Test Kits for and license its proprietary DNA technology to Empower.
VANCOUVER, Aug. 7, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (OTC: EPWCF) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., is pleased to announce it has entered into a strategic partnership with Endocanna Health Inc.(“Endocanna“), a research and development biotechnology company specializing in endocannabinioid DNA testing, and a partly owned subsidiary of Heritage Cannabis (CSE: CANN)
Endocanna will manufacture its patent-pending Endocannabinoid DNA
Test Kits for and license its proprietary DNA technology to Empower.
Empower will immediately make the Endocanna kits available to its
corporate owned medical clinics that include 165,000 patients in Oregon, Arizona, Washington State and Nevada.
The Company plans to include the DNA Test Kits as a standard offering
in the Sun Valley Health franchise program, and has commenced it’s
roll-out in the United States.
“We continue to focus our initiatives on patient care and wellbeing,
ensuring we have the ability to provide best-in-class care and advice
using the most advanced technology available.” said Steven McAuley,
Empowers Chairman & CEO. “The Endocanna DNA Test Kit can give our
physicians the potential to have even greater insight into each
individual patient’s propensity for success, on how CBD based therapies
may interact with their individual regulatory system.”
The Kits are designed to provide consumers with personalized data
about how cannabidiol (CBD) and other cannabinoids may interact with
their body, plus the technology may allow the company to provide
patients with science-backed cannabis product suggestions based on their
specific DNA.
“Using Endocanna Health’s proprietary DNA report, we can personalize
and provide a cannabinoid wellness protocol tailored to an individual’s
needs.” said Len May, CEO & Co-Founder of Endocanna Health. “Empower
and their Sun Valley Health clinic network, provides an immediate
opportunity for us to work with physicians and patients to develop
advanced science surrounding the endocannabinioid system and CBD based
therapies.”
About Endocanna Health Inc.
Endocanna is a company based in Los Angeles, CA that has
developed Endocannabinoid DNA testing to assist individuals in taking
control of their own health, by utilizing cannabis products specifically
suited for themselves. The recently expanded database of genetic
markers now allows for a thorough review of potential products, which
are helpful to address the needs of patients. EndoDNA testing packages
are currently available in the United States, and will shortly be introduced to Canada and other select cannabis-forward countries. For more information visit www.endocannahealth.com
About Heritage Cannabis Holdings Corp.
The Company is focused on becoming a vertically integrated cannabis
provider that currently has two Health Canada approved licenced
producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure
Corp. both regulated under the Cannabis Act Regulations. Working under
these two licences, Heritage has two additional subsidiaries, Purefarma
Solutions, which provides extraction services, and BriteLife Sciences
that is focused on cannabis based medical solutions. Heritage as the
parent Company, is focused on providing resources for its subsidiaries
to advance their products or services to compete both domestically and
internationally.
ABOUT EMPOWER
Empower is a vertically integrated and growth-oriented CBD life
sciences company, and a multi-state operator of medical health &
wellness clinics, operating the Sun Valley Health clinic brand www.sunvalleyhealth.com, for its nine corporate locations and for franchises in the United States.
As a CBD product manufacturer under the Solievo brand, the company
distributes its lines through clinics, online and through retail
partners. Extraction operations are currently being developed in the
Company’s new extraction facility in Oregon.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley Chief Executive Officer
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws. All
statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release. Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding; the Company’s intention to open a hemp-based CBD
extraction facility, the expected benefits to the Company and its
shareholders as a result of the proposed acquisitions and partnerships;
the terms of the proposed acquisitions and partnerships; the
effectiveness of the extraction technology; the expected benefits for
Empower’s patient base and customers; the benefits of CBD based
products; the effect of the approval of the Farm Bill; the growth of the
Company’s patient list and that the Company will be positioned to be a
market-leading service provider for complex patient requirements in 2019
and beyond. Such statements are only projections, are based on
assumptions known to management at this time, and are subject to risks
and uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
forward-looking statements, including; that the Company may not open a
hemp-based CBD extraction facility; that the hemp-based CBD extraction
facility may not be fully operation by Q2 2019 if at all; that
legislative changes may have an adverse effect on the Company’s business
and product development; that the Company may not be able to obtain
adequate financing to pursue its business plan; general business,
economic, competitive, political and social uncertainties; failure to
obtain any necessary approvals in connection with the proposed
acquisitions and partnerships; and other factors beyond the Company’s
control. No assurance can be given that any of the events anticipated by
the forward-looking statements will occur or, if they do occur, what
benefits the Company will obtain from them. Readers are cautioned not to
place undue reliance on the forward-looking statements in this release,
which are qualified in their entirety by these cautionary statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements in this release, whether as a result of new information,
future events or otherwise, except as expressly required by applicable
laws.
Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019
Tags: Cannabis, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Enters Into Strategic Partnership With Heritage #Cannabis Subsidiary Endocanna Health to Create and Sell #Endocannabinoid DNA Test Products $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $CANN.ca
Posted by AGORACOM-JC
at 9:15 PM on Tuesday, August 6th, 2019
SPONSOR: Spyder Cannabis Inc.
(TSX-V: SPDR) An established chain of high-end vape stores in Ontario,
Canada. The company has an aggressive expansion plan already in place
that will focus on Canadian retail and US Hemp-Derived kiosks in high
traffic areas. Click here for more info.
(TSX-V: SPDR)
Retailers See Promise in CBD and Hemp Products
CBD Hemp oil, Doctor holding a bottle of hemp oil, Medical marijuana products including cannabis leaf, cbd and hash oil, alternative medicine
Thanks to the passing of the Farm Bill in late 2018
– containing a provision legalizing hemp, a species of non-psychoactive
cannabis that CBD can be extracted from – Hemp and CBD are on major
retailers’ radar.
The CBD market is moving towards mainstream retailers and is projected to be over $20 Billion in sales by 2024.
Walgreens, Sprout, CVS, Ulta Beauty, GNC Holdings, Urban Outfitters are
just a handful of retailers offering or looking to offer, CBD products
to consumers.
According to Christina Hartwell from Little Mary and Jane â€the industry is on the verge of moving beyond merely CBD and exploring the full spectrum of Hemp (Cannabis Sativa L).â€
The potential of CBD and Hemp products appears to be endless due to newly emerging scientific data.
“The industry is on the verge of
moving beyond merely CBD and exploring the full spectrum of Hemp
(Cannabis Sativa L). Scientific studies thus far have been somewhat
limited due to the stumbling block of THC due to potential adverse side
effects and regulations. However, the studies being done on
full-spectrum Hemp and the multitude of Cannabinoids in the plant are
promising, CBN is beginning to come to the forefront and is potentially
more beneficial for treating Insomnia and Anxiety than Isolated CBD,â€
Hartwell added.
Retailers jumping in
Several retailers for natural
supplements are expected to have CBD on their shelves. Dillards
Department Store, a chain with a total of approximately 292 stores in 29
states, is beginning to roll out several Hemp Depot while labeled CBD
products. Kroger announced in July another 1,000 locations in 22 states where their grocery stores will begin to carry CBD products.
“Because of the tremendous range of
products in which CBD is a fit, we expect to see it on shelves,
literally, everywhere. Wholesale order numbers are climbing
dramatically, which is one of the first signs of significant market
expansion. When we started, we were taking orders for small companies
ordering 500 units at a time. Large company orders are projected to
reach 100,000+ units in the next 18 months which is going allow
wholesalers like Hemp Depot to manufacture products on a larger scale,
thereby reducing CBD product prices by the end of 2020 to a forecasted
$20 – $30 as with standard vitamin supplements,†said Andy Rodosevich,
CEO and Co-Founder of Hemp Depot.
In July, adding to the momentum,
Toronto-headquartered Abacus Health Products announced new retail
purchase orders from CVS for its line of CBDMEDIC pain relief and skincare products, sold to consumers via retail chains and the company’s e-commerce platform.
“We are encouraged to see the
continued interest and growth in CBDMEDIC among leading retailers
throughout the United States. In particular, the fact that CBDMEDIC
products are now being positioned in-line demonstrates the acceptance of
our over-the-counter products within the traditional pain relief and
skincare categories and we look forward to seeing the continued growth
in the number of retail locations in which CBDMEDIC is available,” said Perry Antelman, the CEO of Abacus Health Products, maker of CBD CLINIC and CBDMEDIC.
Also in July, Green Growth Brands announced a deal
with American Eagle to begin selling its CBD-infused body-care products
— including muscle balms and lotions — in nearly 500 of American
Eagle’s stores and online, with sales expected to begin in October. This
follows apparel retailer Abercrombie, which just last month announcing
its plans to sell GGB’s products in more than 160 stores across the U.S.
“The cultural conversation around CBD is growing and I think we are
beyond CBD being only for early adopters. The push to major retail
outlets like Kroger, Walgreens, and CVS seem to support that, said Paul
Miller from Lokus Nutrition.
Risks remain
The FDA is in the midst of creating
guidelines for CBD manufacturers and will likely eliminate some
manufacturers currently participating in the CBD boom and open the door
to some large scale, mainstream manufacturers. The details of the FDA
regulations will inform the specifics of how large the OTC piece of the
CBD pie becomes.
“We’ve seen major chain retailers
like CVS, Walgreens, and Whole Foods start to include CBD in their
product mixes. The larger the entity, the more likely they are to stick
with topical products until the FDA provides clarity,” said Kate Heckman
from Stratos CBD.
When it comes to CBD oils, presently
only 10% of demand is being filled by present growers, the industry has
increased by 200% from 2017 to 2018, about 618 million in sales last
year with projected 22 Billion by 2022.
“A lot of people want to get into
this arena. Some of the problems we are working on are Standardization
of the industry, Genetic variations, for patents and Lab Certification.
It is the wild west, with little or no standard dosages or diagnosis for
the public to rely on,†said John Sation, Clinic Director, and research
Coordinator from Hair & Scalp Clinics.
The recent FDA warning letter to Curaleaf on
July 26 serves as a wake-up call to the industry about statements in
marketing or social media that imply that these products can be used to
treat medical conditions.
“It’s in the best interest of the
industry to be careful and conservative with any label claims being
made. With the passing of the 2018 Farm Bill, each state department of
agriculture must submit a state management plan to the USDA outlining
how various aspects of hemp cultivation and processing will be managed
within their jurisdiction,†said Dr. Sean Callan, CEO of Precision Botanical.
While the opportunity is real, risks remain. According to David Gross from Strategic Value Partners, players in the space should tread carefully as the regulatory framework is currently only taking shape.
“Don’t be first here. By all
indications, the FDA appears poised to take aggressive and decisive
action, as evidenced by the Curaleaf warning letter, against companies
who manufacture, distribute, and retail CBD products. Moreover, the Drug
Enforcement Agency (DEA), Department of Agriculture, and financial
regulators (i.e., FDIC, OOC, and Federal Reserve) remain unknowns. In
the near-term, any benefit you might receive from being first is far
outweighed by the business and reputational risk of a potential FDA
action or a multi-state federal raid at your warehouses.â€
Posted by AGORACOM-JC
at 8:35 AM on Tuesday, August 6th, 2019
BOG:TSX-V
Announced that it has signed a letter of intent (LOI) to provide funding and to acquire up to 39% of the assets and inventory of Thrive Nutrition Products Ltd. (Thrive Wellness)
Thrive Wellness is a preeminent distributor of hemp & cannabinoid-focused natural health products under the “THRIVE WELLNESS†brand.
Thrive has achieved $2,500,000 CND in sales through retail distribution, it’s e-commerce website and their relationship with Nutrition House, Canada’s leading Natural Health Product franchise
VANCOUVER, British Columbia, Aug. 06, 2019 — BOUGAINVILLE VENTURES INC. (CSE: BOG) (FRA: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Bougainville” or the “Company”) is pleased to announce that it has signed a letter of intent (LOI) to provide funding and to acquire up to 39% of the assets and inventory of Thrive Nutrition Products Ltd. (Thrive Wellness). Thrive Wellness is a preeminent distributor of hemp & cannabinoid-focused natural health products under the “THRIVE WELLNESS†brand. The final evaluation will be determined by an independent third party evaluator, which is currently in progress. The Company will acquire up to 39% of Thrive Wellness assets and current inventory. The consideration is to be payable in such number of common shares in its share capital (“Consideration Shares”) at a per share price equal to the volume weighted average price of such shares on the Canadian Securities Exchange over a 15-day period ending on the day such Consideration Shares are required to be issued (“15 day VWAP”).
Thrive Wellness is a distributor of premium hemp and natural health
products with operations currently in Canada and the USA. Thrive
specializes in the development, marketing and distribution of
cannabinoid products refined into their own natural health product
brand. The company was founded in Vancouver, British Columbia and is the
first of its kind with national retail distribution in Canada. Thrive
has achieved $2,500,000 CND in sales through retail distribution, its’
e-commerce website and their relationship with Nutrition House, Canada’s
leading Natural Health Product franchise. Founded in 1979 the company
began franchising in 1993 and now operates over 45 retail stores,
located in high profile shopping centers across Canada, and in the USA. www.nutritionhouse.com
“We are honored to supply our retail partners with premium Hemp
products,†says Andy Dhaliwal, President of Thrive Wellness. “Our
commitment to quality, transparency, and wellness will ensure customers
receive the best products available. We look forward to working with
Bougainville to bring high quality, innovative Hemp products to US and
International markets.â€
Bank of America projects a spend of $1.3 Billion on CBD in Canada by
2022, while $1.9 Billion is being spent in the USA currently, and
another $4.4 Billion in Europe this year. Demand for CBD and Hemp is
increasing year over year, with Merrill Lynch predicting an $11.5
Billion American market by 2032.
Andy Jagpal, President Comments:
“This LOI is a first step in Bougainville and Thrive’s vision to lead
the sector in this global opportunity The Thrive Wellness brand and Mr.
Dhaliwal bring the sales & distribution experience and contacts
needed to succeed in this fledgling natural health & CBD market.â€
About Thrive Nutrition Products Ltd.
Thrive Wellness is a preeminent distributor of premium hemp &
natural health products with a global distribution footprint. A trusted
brand of wellness products with mind share as well as market share,
Thrive has driven value with their pioneering expertise in the emerging
CBD market.
About Bougainville Ventures, Inc. Bougainville
Ventures Inc. is dedicated to rapid growth in production, processing,
retail and branding of cannabis and cannabis related products. Currently
the company provides strategic capital to the thriving cannabis
cultivation sector through ownership and development of commercial real
estate properties. We offer fully built out turnkey facilities equipped
with state-of-the-art growing infrastructure to cannabis growers and
processors. Also, the Company is focused on building a strong presence
in the hemp industry with the objective of extracting cannabinoids in
both Canada and the United States. Along with our flagship Hemp project
in Oregon State and the Greenhouse campus in Washington state, the
Company has proprietary formulas for cannabis edibles, topical, and
tinctures.
On behalf of the Board of Directors BOUGAINVILLE VENTURES INC.
Andy Jagpal, President and Director
For further information, please contact Andy Jagpal at [email protected]. Please note that our Toll free number has changed to 1-877-517-7816.
http://bougainvilleinc.com/
https://twitter.com/bougainvilleinc
FORWARD LOOKING STATEMENTS: This news release
contains certain forward-looking statements within the meaning of
Canadian securities laws. Forward-looking statements are based on the
expectations and opinions of the Company’s management on the date the
statements are made. The assumptions used in the preparation of such
statements, although considered reasonable at the time of preparation,
may prove to be imprecise and, as such, undue reliance should not be
placed on forward-looking statements. The Company expressly disclaims
any intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or
otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.
Tags: CBD, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in Bougainville Ventures | Comments Off on Bougainville Ventures Inc. $BOG.ca Signs LOI to enter in to Funding and Asset Purchase Agreement up to 39% with Thrive Nutrition Products Ltd. $CROP.ca $VP.ca NF.ca $MCOA
